Stockreport

FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million

FibroGen, Inc  (FGEN) 
Last fibrogen, inc earnings: 3/2 04:01 pm Check Earnings Report
PDF  Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently estimated to be approximately $75 millionUpon close [Read more]